-
EP1159961
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP1159961
| EP1159961 - Treatment of tumors with compounds having RxR retinoid receptor agonist activity [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 21.10.2005 Database last updated on 20.07.2024 | Most recent event Tooltip | 01.08.2008 | Change - applicant | published on 03.09.2008 [2008/36] | Applicant(s) | For all designated states ALLERGAN, INC. 2525 Dupont Drive Irvine, CA 92612 / US | For all designated states Board of Regents, The University of Texas System 201 West 7th Street Austin, TX 78701 / US | [N/P] |
| Former [2008/36] | For all designated states ALLERGAN, INC. 2525 Dupont Drive Irvine CA 92612 / US | ||
| For all designated states Board of Regents, The University of Texas System 201 West 7th Street Austin Texas 78701 / US | |||
| Former [2001/49] | For all designated states ALLERGAN, INC. 2525 Dupont Drive, P.O. Box 19534 Irvine, California 92713-9534 / US | ||
| For all designated states Board of Regents, The University of Texas System 201 West 7th Street Austin Texas 78701 / US | Inventor(s) | 01 /
Davies, Peter A J. 5503 Cheltenham Drive Houston, TX 77096 / US | 02 /
Chandraratna, Roshantha A. 25241 Buckskin Laguna Hills, CA 92653 / US | [2001/49] | Representative(s) | Hutchins, Michael Richard FRY HEATH & SPENCE LLP The Gables Massetts Road Horley Surrey RH6 7DQ / GB | [N/P] |
| Former [2001/49] | Hutchins, Michael Richard FRY HEATH & SPENCE The Old College 53 High Street Horley Surrey RH6 7BN / GB | Application number, filing date | 00127736.7 | 10.03.1994 | [2001/49] | Priority number, date | US19930029801 | 11.03.1993 Original published format: US 29801 | [2001/49] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | EP1159961 | Date: | 05.12.2001 | Language: | EN | [2001/49] | Type: | A3 Search report | No.: | EP1159961 | Date: | 22.05.2002 | [2002/21] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 10.04.2002 | Classification | IPC: | A61K31/38, A61K31/00 | [2002/20] | CPC: |
A61K31/381 (EP,US);
A61K31/00 (EP,US);
A61K31/192 (EP,US);
A61K31/38 (EP,US);
A61P35/00 (EP);
A61P35/04 (EP);
A61P43/00 (EP)
(-)
|
| Former IPC [2001/50] | A61K31/00, A61K31/192, A61K31/381, A61P35/00, A61P35/04 | ||
| Former IPC [2001/49] | A61K31/381, A61P35/04 | Designated contracting states | AT, BE, CH, DE, DK, ES, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [2001/49] | Title | German: | Behandlung von Tumoren mit Verbindungen mit einer RXR-Retinoid-Agonistischer Wirkung | [2001/49] | English: | Treatment of tumors with compounds having RxR retinoid receptor agonist activity | [2001/49] | French: | Traitement des tumeurs à l'aide de composés présentant une activité d'agoniste du récepteur de rétinoides RXR | [2001/49] | Examination procedure | 16.01.2001 | Examination requested [2001/49] | 13.11.2003 | Despatch of a communication from the examining division (Time limit: M06) | 20.05.2004 | Reply to a communication from the examining division | 24.01.2005 | Despatch of a communication from the examining division (Time limit: M04) | 06.06.2005 | Application deemed to be withdrawn, date of legal effect [2005/49] | 08.07.2005 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2005/49] | Parent application(s) Tooltip | EP94911529.9 / EP0688213 | Fees paid | Renewal fee | 16.01.2001 | Renewal fee patent year 03 | 16.01.2001 | Renewal fee patent year 04 | 16.01.2001 | Renewal fee patent year 05 | 16.01.2001 | Renewal fee patent year 06 | 16.01.2001 | Renewal fee patent year 07 | 16.01.2001 | Renewal fee patent year 08 | 22.03.2002 | Renewal fee patent year 09 | 24.03.2003 | Renewal fee patent year 10 | 22.03.2004 | Renewal fee patent year 11 | Penalty fee | Additional fee for renewal fee | 31.03.2005 | 12 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A]DE3202118 (BASF AG [DE]) [A] 1-5 * page 2 - page 6 * * page 12 *; | [PX]WO9321146 (LIGAND PHARM INC [US]) [PX] 1-5 * page 5 * * page 56 * * page 59, line 15 - line 26 * * page 68, line 29 - line 34 * * page 70 - page 71 * * claims 3,11,20,21,37 *; | [X] - ANONYM, PHARMPAT, CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US, (1993), XP002194368 [X] 1-4 * see paragraph "preclinical" in the abstract * | [PX] - CESARIO R M ET AL, "Growth inhibition of multiple melanoma and squamous cell carcinoma by 9-cis retinoic acid.", PROC.AM.ASSOC.CANCER RES. (35, 85 MEET., 275, 1994), XP001064370 [PX] 1 * abstract nr 1645 * | [PX] - SCRIP, (19931210), vol. 1880, page 9, XP008001481 [PX] 1 * the whole document * | [A] - STRICKLAND S ET AL, "STRUCTURE-ACTIVITY RELATIONSHIPS OF A NEW SERIES OF RETINOIDAL BENZOIC ACID DERIVATIVES A MEASURED BY INDUCTION OF DIFFERENTIATIONOF MURINE F9 TERATOCARCINOMA CELLS AND HUMAN HL-60 PROMYELOCYTIC LEUKEMIA CELLS", CANCER RESEARCH, AMERICAN ASSOCIATION FOR CANCER RESEARCH, BALTIMORE, MD, US, (198311), vol. 43, no. 11, ISSN 0008-5472, pages 5268 - 5272, XP008001075 [A] 1-5 * the whole document * |